The University of Cincinnati is a public research university in Cincinnati, Ohio. Founded in 1819 as Cincinnati College, it is the oldest institution of higher education in Cincinnati and has an annual enrollment of over 44,000 students, making it the second largest university in Ohio.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
University of Cincinnati
116
National Institute of Allergy and Infectious Diseases (NIAID)
61
National Cancer Institute (NCI)
20
Shire
13
Bristol-Myers Squibb
11
Gilead Sciences
11
United Therapeutics
10
Actelion
9
Johns Hopkins University
8
Health Decisions
7
Radiation Therapy Oncology Group
7
Clinical Trials at University of Cincinnati
During the past decade, University of Cincinnati conducted 297 clinical trials. In the 10-year time frame, 297 clinical trials started and 182 clinical trials were completed, i.e. on
average, 61.3% percent of trials that started reached the finish line to date. In the past 5 years, 101 clinical trials started and 83 clinical trials were completed. i.e. 82.2%
of trials that started reached the finish line.
Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients
A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)
A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection
A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months
1997-06-01
Completed
1,750
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University of Cincinnati" #1 sponsor was "University of Cincinnati" with 116 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 61 trials
sponsored, "National Cancer Institute (NCI)" with 20 trials sponsored, "Shire" with 13 trials sponsored and "Bristol-Myers Squibb"
with 13 trials sponsored. Other sponsors include 497 different institutions and
companies that sponsored additional 308 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Cincinnati"
#1 collaborator was "University of Cincinnati" with 32 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 30 trials as a collaborator, "National Cancer Institute (NCI)" with 26 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 20 trials as a collaborator and "NRG Oncology" with 14 trials as a collaborator. Other collaborators include 498 different institutions and companies that were
collaborators in the rest 274 trials.
Clinical Trials Conditions at University of Cincinnati
According to Clinical.Site data, the most researched conditions in "University of Cincinnati" are
"HIV Infections" (68 trials), "Pulmonary Arterial Hypertension" (20 trials), "Heart Failure" (18 trials), "Stroke" (16 trials) and "Parkinson Disease" (13 trials). Many other conditions were trialed in "University of Cincinnati" in a lesser frequency.
Clinical Trials Intervention Types at University of Cincinnati
Most popular intervention types in "University of Cincinnati" are "Drug" (471 trials), "Other" (85 trials), "Device" (61 trials), "Biological" (49 trials) and "Behavioral" (37 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (127 trials), "Zidovudine" (12 trials), "Bevacizumab" (11 trials), "Laboratory Biomarker Analysis" (11 trials) and "placebo" (11 trials). Other intervention names were less common.
Clinical Trials Genders at University of Cincinnati
The vast majority of trials in "University of Cincinnati" are
645 trials for "All" genders, 68 trials for "Female" genders and 10 trials for "Male" genders.
Clinical Trials Status at University of Cincinnati
Currently, there are 166 active trials in "University of Cincinnati".
4 are not yet recruiting,
94 are recruiting,
63 are Active, not recruiting,
and 5 are Enrolling by invitation.
In total, there were 414 completed trials in University of Cincinnati,
5 suspended trials,
and 82 terminated clinical trials to date.
Out of the total trials that were conducted in University of Cincinnati, 53 "Phase 1"
clinical trials were conducted, 236 "Phase 2" clinical
trials and 209 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 45 trials, and there were
also 95 trials that are defined as “Not Applicable".
Departments of University of Cincinnati
University of Cincinnati has several departments that took part in Clinical trials: "Charles M. Barrett Cancer Center at University Hospital" - 119 trials, "University of Cincinnati Department of Psychiatry and Behavioral Neuroscience" - 22 trials, "Univ. of Cincinnati CRS (2401)" - 21 trials, "University of Cincinnati; Department of Neurology" - 11 trials, "University of Cincinnati - Department of Internal Medicine Pulmonary, Critical Care & Sleep Medicine" - 5 trials, "University of Cincinnati College of Nursing" - 3 trials, "Dermatology Research Center of Cincinnati" - 3 trials, "University of Cincinnati Department of Emergency Medicine" - 3 trials, "University of Cincinnati - Department of Internal Medicine" - 3 trials, "University Neurology-Movement Disorders Clinic" - 2 trials, "University of Cincinnati - Division of Nephrology" - 2 trials, "Women's Health Research Program" - 2 trials, "University of Cincinnati AIDS Clinical Trials Unit" - 2 trials, "University of Cincinnati (UC) - Cancer Institute" - 2 trials, "Psychology Department, University of Cincinnati" - 2 trials, "University of Cincinnati Barrett Center" - 2 trials